Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

UPDATE 1-UK reports new daily vaccine record with 660,276 shots

Fri, 19th Mar 2021 16:35

(Adds vaccine daily record)

LONDON, March 19 (Reuters) - Britain on Friday said it had
given 660,276 doses of COVID-19 vaccine in a single day, a new
daily record, in a boost to the rollout before the country
prepares for a drop-off in the "bumper" supplies of shots.

The single day record for first and second doses comes as
Britain approaches the milestone of giving half their adult
population at least one COVID-19 vaccine.

Israel is the leader in vaccinating its population, followed
by the United Arab Emirates, Chile and then the United Kingdom -
and investors are watching closely to see which economies could
recover first.

Britain's official data showed that 26.264 million people
had received a first dose of the vaccine, and 2.011 million
people had received a second. It also recorded 101 new deaths of
people who had tested positive for COVID-19 within 28 days, and
4,802 new cases of the disease.

Distributed by the state-run health service, Britain's
vaccine rollout has got off to a blistering start but the
government has warned this week of a marked slowdown in April
due to a delay of a shipment from India's Serum Institute and
because a batch in the UK needed to be retested.

Prime Minister Boris Johnson, who is due to receive his own
first vaccine on Friday, said the two issues meant supplies in
April would be lower than they were in March.

Britain has so far relied on vaccines from AstraZeneca
and Oxford University, and Pfizer and BioNTech
.
(Reporting by Andrew MacAskill and Alistair Smout; Editing by
Kate Holton)

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.